Madam Chair, as I said in answer to an earlier question, I will not comment on the nature of the process with respect to SNC-Lavalin and DPAs because there is an ongoing appellate procedure, and anything I can say or do might be interpreted as having taken a stance in that matter.
In the House of Commons on May 14th, 2019. See this statement in context.